Multivariate analysis showed that, together with the patients’ age and tumor stage, MAGE-A10 expression by tumor cells was an independent predictor of unresponsiveness to first-line platinum treatment (p = 0.005) (Table 3). The gene discussed is MAGEA10; the disease is neoplasm.